Abstract:This paper introduces a new class of amphiphilic block copolymers created by combining two polymers: polylactic acid (PLA), a biocompatible and biodegradable hydrophobic polyester used for cargo encapsulation, and a hydrophilic polymer composed of oligo ethylene glycol chains (triethylene glycol methyl ether methacrylate, TEGMA), which provides stability and repellent properties with added thermo-responsiveness. The PLA-b-PTEGMA block copolymers were synthesized using ring-opening polymerization (ROP) and reversible addition-fragmentation chain transfer (RAFT) polymerization (ROP-RAFT), resulting in varying ratios between the hydrophobic and hydrophilic blocks. Standard techniques, such as size exclusion chromatography (SEC) and 1H NMR spectroscopy, were used to characterize the block copolymers, while 1H NMR spectroscopy, 2D nuclear Overhauser effect spectroscopy (NOESY), and dynamic light scattering (DLS) were used to analyze the effect of the hydrophobic PLA block on the LCST of the PTEGMA block in aqueous solutions. The results show that the LCST values for the block copolymers decreased with increasing PLA content in the copolymer. The selected block copolymer presented LCST transitions at physiologically relevant temperatures, making it suitable for manufacturing nanoparticles (NPs) and drug encapsulation-release of the chemotherapeutic paclitaxel (PTX) via temperature-triggered drug release mechanism. The drug release profile was found to be temperature-dependent, with PTX release being sustained at all tested conditions, but substantially accelerated at 37 and 40 °C compared to 25 °C. The NPs were stable under simulated physiological conditions. These findings demonstrate that the addition of hydrophobic monomers, such as PLA, can tune the LCST temperatures of thermo-responsive polymers, and that PLA-b-PTEGMA copolymers have great potential for use in drug and gene delivery systems via temperature-triggered drug release mechanisms in biomedicine applications.

Biodegradable block copolymer matrices for long-acting contraceptives with constant release

Biodegradable Polymeric Matrix for Long‐acting and Zero‐order Release Drug Delivery Systems

Amphiphilic Block Copolymers Based on Methoxy Poly(ethylene Glycol) and Either Crystalline or Amorphous Poly(caprolactone‐b‐lactide): Synthesis, Solid‐state and Aqueous Solution Characterizations

Synthesis and Drug Controlled Release of Block Copolymers of Poly(l‐lactide) with Poly(d, L‐lactide) and Related Monomers

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Synthesis, Self-Assembly, Drug-Release Behavior, And Cytotoxicity Of Triblock And Pentablock Copolymers Composed Of Poly(Epsilon-Caprolactone), Poly(L-Lactide), And Poly(Ethylene Glycol)

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

A biodegradable long-term contraceptive implant with steady levonorgestrel release based on PLGA microspheres embedded in PCL-coated implant

Synthesis, characterization and biocompatibility of novel biodegradable poly[((R)-3-hydroxybutyrate)-block-(D,L-lactide)-block-(ɛ-caprolactone)] triblock copolymers

Controlled Release of Levonorgestrel from Biodegradable Poly(d,l-Lactide-co-glycolide) Microspheres: in Vitro and in Vivo Studies.

Smart Poly(lactide)- b-poly(triethylene glycol methyl ether methacrylate) (PLA- b-PTEGMA) Block Copolymers: One-Pot Synthesis, Temperature Behavior, and Controlled Release of Paclitaxel

Short Poly(ethylene Glycol) Block Initiation of Poly(l‐lactide) Di‐block Copolymers: a Strategy for Tuning the Degradation of Resorbable Devices

Biodegradable comb-dendritic tri-block copolymers consisting of poly(ethylene glycol) and poly(l-lactide): Synthesis, characterizations, and regulation of surface morphology and cell responses

A New Generation of Poly(lactide/ε-Caprolactone) Polymeric Biomaterials for Application in the Medical Field.

Novel Amphiphilic, Biodegradable, Biocompatible, Thermo-Responsive ABA Triblock Copolymers Based on PCL and PEG Analogues via a Combination of ROP and RAFT: Synthesis, Characterization, and Sustained Drug Release from Self-Assembled Micelles

Biodegradable Shape‐memory Polymer—polylactide‐co‐poly(glycolide‐co‐caprolactone) Multiblock Copolymer

Novel Biodegradable and Double Crystalline Multiblock Copolymers Comprising of Poly(butylene Succinate) and Poly(ε-caprolactone): Synthesis, Characterization, and Properties

Triblock and pentablock copolymerizations of ε-caprolactone with L-lactide catalyzed by N-heterocyclic carbene

Syntheses and properties of tri- and multi-block copolymers consisting of polybutadiene and polylactide segments

Synthesis and characterization of star-shaped block copolymer of poly-(ε-caprolactone) and poly(ethyl ethylene phosphate) as drug carrier